Capital Counsel’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $7.6M | Hold |
63,213
| – | – | 0.32% | 19 |
|
|
2025
Q4 | $6.65M | Hold |
63,213
| – | – | 0.25% | 19 |
|
|
2025
Q3 | $5.31M | Sell |
63,213
-15
| -0% | -$1.24K | 0.2% | 20 |
|
|
2025
Q2 | $5.01M | Buy |
63,228
+1,120
| +2% | +$89K | 0.2% | 20 |
|
|
2025
Q1 | $5.57M | Sell |
62,108
-73
| -0.1% | -$6.82K | 0.25% | 19 |
|
|
2024
Q4 | $6.19M | Sell |
62,181
-25
| -0% | -$2.58K | 0.26% | 18 |
|
|
2024
Q3 | $7.06M | Buy |
62,206
+23
| +0% | +$2.73K | 0.3% | 17 |
|
|
2024
Q2 | $7.7M | Hold |
62,183
| – | – | 0.34% | 16 |
|
|
2024
Q1 | $8.21M | Hold |
62,183
| – | – | 0.38% | 16 |
|
|
2023
Q4 | $6.78M | Hold |
62,183
| – | – | 0.33% | 16 |
|
|
2023
Q3 | $6.4M | Hold |
62,183
| – | – | 0.36% | 16 |
|
|
2023
Q2 | $7.18M | Hold |
62,183
| – | – | 0.4% | 16 |
|
|
2023
Q1 | $6.62M | Hold |
62,183
| – | – | 0.38% | 16 |
|
|
2022
Q4 | $6.9M | Hold |
62,183
| – | – | 0.43% | 15 |
|
|
2022
Q3 | $5.36M | Hold |
62,183
| – | – | 0.35% | 16 |
|
|
2022
Q2 | $5.67M | Hold |
62,183
| – | – | 0.35% | 16 |
|
|
2022
Q1 | $5.1M | Sell |
62,183
-50
| -0.1% | -$3.94K | 0.24% | 17 |
|
|
2021
Q4 | $4.77M | Sell |
62,233
-143
| -0.2% | -$11.4K | 0.2% | 19 |
|
|
2021
Q3 | $4.68M | Sell |
62,376
-2,815
| -4% | -$214K | 0.23% | 19 |
|
|
2021
Q2 | $5.07M | Sell |
65,191
-35,382
| -35% | -$2.63M | 0.25% | 17 |
|
|
2021
Q1 | $7.4M | Hold |
100,573
| – | – | 0.41% | 16 |
|
|
2020
Q4 | $7.85M | Hold |
100,573
| – | – | 0.46% | 16 |
|
|
2020
Q3 | $7.96M | Sell |
100,573
-105
| -0.1% | -$8.22K | 0.54% | 15 |
|
|
2020
Q2 | $7.43M | Hold |
100,678
| – | – | 0.54% | 15 |
|
|
2020
Q1 | $7.39M | Sell |
100,678
-2,427
| -2% | -$191K | 0.59% | 16 |
|
|
2019
Q4 | $8.95M | Buy |
103,105
+786
| +0.8% | +$64.6K | 0.59% | 18 |
|
|
2019
Q3 | $8.22M | Sell |
102,319
-1,153
| -1% | -$92.4K | 0.58% | 17 |
|
|
2019
Q2 | $8.28M | Hold |
103,472
| – | – | 0.55% | 18 |
|
|
2019
Q1 | $8.21M | Hold |
103,472
| – | – | 0.6% | 17 |
|
|
2018
Q4 | $7.54M | Hold |
103,472
| – | – | 0.63% | 18 |
|
|
2018
Q3 | $7M | Sell |
103,472
-2,044
| -2% | -$130K | 0.49% | 20 |
|
|
2018
Q2 | $6.11M | Hold |
105,516
| – | – | 0.47% | 20 |
|
|
2018
Q1 | $5.48M | Sell |
105,516
-791
| -0.7% | -$42.7K | 0.44% | 22 |
|
|
2017
Q4 | $5.71M | Buy |
106,307
+72
| +0.1% | +$3.99K | 0.47% | 23 |
|
|
2017
Q3 | $6.49M | Sell |
106,235
-744
| -0.7% | -$45.1K | 0.58% | 20 |
|
|
2017
Q2 | $6.54M | Sell |
106,979
-251
| -0.2% | -$15.3K | 0.6% | 20 |
|
|
2017
Q1 | $6.5M | Buy |
107,230
+2,078
| +2% | +$126K | 0.62% | 20 |
|
|
2016
Q4 | $5.91M | Hold |
105,152
| – | – | 0.61% | 22 |
|
|
2016
Q3 | $6.26M | Buy |
105,152
+4,628
| +5% | +$271K | 0.56% | 21 |
|
|
2016
Q2 | $5.53M | Sell |
100,524
-4,513
| -4% | -$240K | 0.51% | 21 |
|
|
2016
Q1 | $5.3M | Sell |
105,037
-1,529
| -1% | -$74.9K | 0.48% | 21 |
|
|
2015
Q4 | $5.37M | Buy |
106,566
+452
| +0.4% | +$22.8K | 0.28% | 33 |
|
|
2015
Q3 | $5M | Sell |
106,114
-4,611
| -4% | -$245K | 0.26% | 35 |
|
|
2015
Q2 | $6.01M | Hold |
110,725
| – | – | 0.3% | 33 |
|
|
2015
Q1 | $6.07M | Hold |
110,725
| – | – | 0.29% | 32 |
|
|
2014
Q4 | $6M | Buy |
110,725
+181
| +0.2% | +$10.1K | 0.28% | 32 |
|
|
2014
Q3 | $6.25M | Hold |
110,544
| – | – | 0.35% | 27 |
|
|
2014
Q2 | $6.1M | Buy |
110,544
+105
| +0.1% | +$5.73K | 0.33% | 26 |
|
|
2014
Q1 | $5.98M | Sell |
110,439
-1,048
| -0.9% | -$54.3K | 0.33% | 27 |
|
|
2013
Q4 | $5.32M | Sell |
111,487
-419
| -0.4% | -$19.2K | 0.3% | 29 |
|
|
2013
Q3 | $5.08M | Sell |
111,906
-329
| -0.3% | -$15K | 0.3% | 30 |
|
|
2013
Q2 | $4.97M | Buy |
+112,235
| New | +$5.01M | 0.3% | 32 |
|
Other funds holding MRK
VCM
VPM
Capital Counsel's MRK Position: Q1 2026 in Review
Capital Counsel held its Merck (MRK) position steady in Q1 2026 at 63,213 shares worth $7.6M. The position accounts for 0.32% of the portfolio, ranked #19.
Capital Counsel first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.95M in Q4 2019. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Capital Counsel held 63,213 shares of Merck worth $7.6M as of Q1 2026.
- Capital Counsel left its Merck share count unchanged in Q1 2026.
- Merck made up 0.32% of Capital Counsel's portfolio in Q1 2026, its #19 holding.
- Capital Counsel first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
- Capital Counsel's Merck position peaked at $8.95M in Q4 2019.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Capital Counsel's 13F filing for Q1 2026, filed 15 May 2026.